Tuhura Biosciences Inc stock is traded at $1.63, with a volume of 83,392. It is up +0.93% in the last 24 hours and down -16.67% over the past month. TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Previous Close:
$1.61
Open:
$1.63
24h Volume:
83,392
Relative Volume:
0.15
Market Cap:
$103.56M
Revenue:
-
Net Income/Loss:
-$30.92M
P/E Ratio:
-
EPS:
-$0.6029
Net Cash Flow:
-$27.39M
1W Performance:
-15.80%
1M Performance:
-16.67%
6M Performance:
-36.02%
1Y Performance:
-33.67%
1-Day Range:
$1.60$1.67
1-Week Range:
$1.56$1.99
52-Week Range:
$0.41$3.43
Tuhura Biosciences Inc Stock (HURA) Company Profile
Name
Tuhura Biosciences IncSector
HealthcareIndustry
BiotechnologyPhone
813-875-6600Address
10500 UNIVERSITY CENTER DR., TAMPA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS